BETA
Your AI-Trained Oncology Knowledge Connection!
Sharyn N. Lewin, MD, discusses the importance of screening patients with ovarian cancer for a BRCA mutation.
Stay up to date on practice-changing data in community practice.
Dr Srour Presents Promising Phase 1 Results for ALLO-316 in ccRCC
Read More
Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning
Xiaojie Zhang, MD, and Akshat Singhal, PhD, discuss their research leveraging deep learning to predict how patients with ER+/HER2- breast cancer will respond to palbociclib.
Listen
Dr Hankins Investigates Erectile Dysfunction Risk After Prostate Cancer Radiation
A new study reveals that rectal spacers during prostate cancer radiation therapy significantly reduce long-term erectile dysfunction rates, enhancing patient outcomes.
The Future of Breast Cancer Care: Blackwood on Personalized Approaches
In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.
Long-Term Data Validates IsoPSA for Prostate Cancer Risk Stratification
Dr Klempner Highlights Practice-Changing Role of Durvalumab/FLOT in Gastric Cancer
Durvalumab enhances event-free survival in resectable gastric and gastroesophageal cancers, revolutionizing neoadjuvant therapy according to the MATTERHORN trial.